The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Drug delivery vehicles on a nano-engineering perspective
Open accessAbstract
Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
Huang, X., & Brazel, C. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00248-6 · Cited by 1,813
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Mechanisms of polymer degradation and erosion
Göpferich, A. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85755-3 · Cited by 1,781
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Why degradable polymers undergo surface erosion or bulk erosion
Burkersroda, F. V., Schedl, L., & Göpferich, A. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00170-9 · Cited by 1,146
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Maintenance Therapy with Certolizumab Pegol for Crohn's Disease
Schreiber, S., Khaliq-Kareemi, M., Lawrance, I. C., Thomsen, O. Ø., Hanauer, S. B., McColm, J., Bloomfield, R., & Sandborn, W. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062897 · Cited by 1,043
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles
Karnik, R., Gu, F., Basto, P., Cannizzaro, C., Dean, L., Kyei-Manu, W., Langer, R., & Farokhzad, O. C. (2008) · Nano Letters · doi:10.1021/nl801736q · Cited by 887
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765
Stimuli-responsive polymers: Biomedical applications and challenges for clinical translation
Hoffman, A. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.004 · Cited by 759
Yamaoka, T., Tabata, Y., & Ikada, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830432 · Cited by 748
Responsive polymeric delivery systems
Kost, J., & Langer, R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00136-8 · Cited by 747
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Recent advances of chitosan nanoparticles as drug carriers
Zeng, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17296 · Cited by 665
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.58.1423 · Cited by 660
Antibody–drug conjugates: targeted drug delivery for cancer
Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 656
Nanonization strategies for poorly water-soluble drugs
Chen, H., Khemtong, C., Yang, X., Chang, X., & Gao, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.009 · Cited by 642
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Stimuli-responsive polymers and their applications in drug delivery
Bawa, P., Pillay, V., Choonara, Y. E., & du Toit, L. C. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/2/022001 · Cited by 641
Ultrasonic drug delivery – a general review
Pitt, W. G., Husseini, G. A., & Staples, B. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.37 · Cited by 621
Advances in drug delivery via electrospun and electrosprayed nanomaterials
Ramakrishna, S., Zamani, M., & Prabhakaran, M. P. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43575 · Cited by 596
Self-citationHamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Kirby, C., Clarke, J., & Gregoriadis, G. (1980) · Biochemical Journal · doi:10.1042/bj1860591 · Cited by 592
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
Rosenholm, J. M., Sahlgren, C., & Lindén, M. (2010) · Nanoscale · doi:10.1039/c0nr00156b · Cited by 572
Liposomes: Technologies and Analytical Applications
Jesorka, A., & Orwar, O. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.112747 · Cited by 569
Control of encapsulation efficiency and initial burst in polymeric microparticle systems
Yeo, Y., & Park, K. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980037 · Cited by 567
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Preparation and characterization of liposomes as therapeutic delivery systems: a review
Vemuri, S., & Rhodes, C. T. (1995) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00010-7 · Cited by 564
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S.-D., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562
Nanostructure-mediated drug delivery
Hughes, G. A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2004.11.009 · Cited by 561
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG block copolymer
Yoo, H. S., & Park, T. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00340-0 · Cited by 538
Light‐sensitive Intelligent Drug Delivery Systems†
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519
Photochemical mechanisms of light-triggered release from nanocarriers
Fomina, N., Sankaranarayanan, J., & Almutairi, A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.006 · Cited by 491
Silverman, J. A., & Deitcher, S. R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2042-4 · Cited by 474
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Duncan, B., Kim, C., & Rotello, V. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.004 · Cited by 469
Micelles and nanoparticles for ultrasonic drug and gene delivery
Husseini, G. A., & Pitt, W. G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.008 · Cited by 468
Shum, H. C., Kim, J.-W., & Weitz, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802157y · Cited by 445
Electrospraying of polymers with therapeutic molecules: State of the art
Bock, N., Dargaville, T. R., & Woodruff, M. A. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.03.002 · Cited by 440
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Kim, D.-H., & Martin, D. C. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.12.021 · Cited by 430
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Deconstructing the Drug Development Process: The New Face of Innovation
Kaitin, K. I. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.293 · Cited by 418
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Fritze, A., Hens, F., Kimpfler, A., Schubert, R., & Peschka-Süss, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.028 · Cited by 416
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Ta, T., & Porter, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.036 · Cited by 403
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Microfluidic methods for forming liposomes
van Swaay, D., & deMello, A. (2013) · Lab on a Chip · doi:10.1039/c2lc41121k · Cited by 379
Molecular design of biodegradable polymeric micelles for temperature-responsive drug release
Nakayama, M., Okano, T., Miyazaki, T., Kohori, F., Sakai, K., & Yokoyama, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.007 · Cited by 376
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Seifalian, A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16923 · Cited by 366
Grüll, H., & Langereis, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.041 · Cited by 360
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357
Senior, J., & Gregoriadis, G. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90455-6 · Cited by 355
Liposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Engineered polymers for advanced drug delivery
Kim, S., Kim, J.-H., Jeon, O., Kwon, I. C., & Park, K. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.021 · Cited by 355
Nanomedicine, nanotechnology in medicine
Boisseau, P., & Loubaton, B. (2011) · Comptes Rendus. Physique · doi:10.1016/j.crhy.2011.06.001 · Cited by 354
Faisant, N., Siepmann, J., & Benoit, J. P. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00023-4 · Cited by 346
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience
Adler-Moore, J., & Proffitt, R. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.21 · Cited by 339
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.025 · Cited by 334
Maeng, J. H., Lee, D.-H., Jung, K. H., Bae, Y.-H., Park, I.-S., Jeong, S., Jeon, Y.-S., Shim, C.-K., Kim, W., Kim, J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.068 · Cited by 333
Bottom-up strategy of materials fabrication: a new trend in nanotechnology of soft materials
Shimomura, M., & Sawadaishi, T. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00081-9 · Cited by 331
Dinndorf, P. A., Gootenberg, J., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-991 · Cited by 324
A New Two‐Photon‐Sensitive Block Copolymer Nanocarrier
Babin, J., Pelletier, M., Lepage, M., Allard, J., Morris, D., & Zhao, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900255 · Cited by 305
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Masayuki, Y., Mizue, M., Noriko, Y., Teruo, O., Yasuhisa, S., Kazunori, K., & Shohei, I. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90139-k · Cited by 290
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon, H.-Y., Lee, J.-Y., Choi, S.-W., Jang, Y., & Kim, J.-H. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00825-6 · Cited by 286
Nyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
Sukhorukov, G. B., Rogach, A. L., Zebli, B., Liedl, T., Skirtach, A. G., Köhler, K., Antipov, A. A., Gaponik, N., Susha, A. S., Winterhalter, M., et al. (2005) · Small · doi:10.1002/smll.200400075 · Cited by 280
Responsive polymeric delivery systems
Kost, J., & Langer, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.014 · Cited by 268
Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles
Chalasani, K. B., Russell-Jones, G. J., Jain, A. K., Diwan, P. V., & Jain, S. K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.019 · Cited by 257
Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification
Pouton, C. W. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90081-x · Cited by 255
Hayashi, K., Ono, K., Suzuki, H., Sawada, M., Moriya, M., Sakamoto, W., & Yogo, T. (2010) · ACS Applied Materials & Interfaces · doi:10.1021/am100237p · Cited by 254
Sajeesh, S., & Sharma, C. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.019 · Cited by 250
Göpferich, A. (1997) · Macromolecules · doi:10.1021/ma961627y · Cited by 245
Waterhouse, D. N., Tardi, P. G., Mayer, L. D., & Bally, M. B. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00004 · Cited by 242
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Schroeder, A., Avnir, Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y., Kost, J., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la0631668 · Cited by 239
The Design of Nanoparticles Obtained by Solvent Evaporation: A Comprehensive Study
Desgouilles, S., Vauthier, C., Bazile, D., Vacus, J., Grossiord, J.-L., Veillard, M., & Couvreur, P. (2003) · Langmuir · doi:10.1021/la034999q · Cited by 238
Surface Chemistry of Biodegradable Polymers for Drug Delivery Systems
Ha, C.-S., & Gardella, J. A. (2005) · Chemical Reviews · doi:10.1021/cr040419y · Cited by 229
Bhatta, R. S., Chandasana, H., Chhonker, Y. S., Rathi, C., Kumar, D., Mitra, K., & Shukla, P. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.060 · Cited by 224
Osada, K., Christie, R. J., & Kataoka, K. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0547.focus · Cited by 218
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
Keating, M. J., Holmes, R., Lerner, S., & Ho, D. H. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309149129 · Cited by 217
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Bolotin, E. M., Cohen, R., Bar, L. K., Emanuel, N., Ninio, S., Barenholz, Y., & Lasic, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037057 · Cited by 207
Xie, J., Marijnissen, J. C. M., & Wang, C.-H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.034 · Cited by 207
Okada, H., Doken, Y., Ogawa, Y., & Toguchi, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018936815654 · Cited by 206
Development of liposomal formulations: From concept to clinical investigations
Fan, Y., & Zhang, Q. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.010 · Cited by 206
Stimulus-Responsive Macromolecules and Nanoparticles for Cancer Drug Delivery
MacEwan, S. R., Callahan, D. J., & Chilkoti, A. (2010) · Nanomedicine · doi:10.2217/nnm.10.50 · Cited by 201
UV- and NIR-responsive polymeric nanomedicines for on-demand drug delivery
Liu, G., Liu, W., & Dong, C.-M. (2013) · Polymer Chemistry · doi:10.1039/c3py21121e · Cited by 195
Wang, L., Su, W., Liu, Z., Zhou, M., Chen, S., Chen, Y., Lu, D., Liu, Y., Fan, Y., Zheng, Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.067 · Cited by 193
Poon, R. T., & Borys, N. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802677874 · Cited by 189
Zhigaltsev, I. V., Maurer, N., Akhong, Q.-F., Leone, R., Leng, E., Wang, J., Semple, S. C., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.010 · Cited by 186
Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds
Jaklenec, A., Hinckfuss, A., Bilgen, B., Ciombor, D. M., Aaron, R., & Mathiowitz, E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.004 · Cited by 185
DEMEL, R. A., Kinsky, S. C., Kinsky, C. B., & Deenen, L. L. M. V. (1968) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(68)90055-2 · Cited by 184
Wiseman, G. A., White, C. A., Sparks, R. B., Erwin, W. D., Podoloff, D. A., Lamonica, D., Bartlett, N. L., Anthony Parker, J., Dunn, W. L., Spies, S. M., et al. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00107-x · Cited by 183
Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray
Xie, J., Ng, W. J., Lee, L. Y., & Wang, C.-H. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2007.09.082 · Cited by 181
Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
Goldsmith, S. J. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.11.002 · Cited by 171
Nanocarriers for intravenous injection—The long hard road to the market
Wacker, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.079 · Cited by 170
Nanoparticle Therapeutics: FDA Approval, Clinical Trials, Regulatory Pathways, and Case Study
Eifler, A. C., & Thaxton, C. S. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-052-2_21 · Cited by 168
Polymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 165
Tagami, T., Ernsting, M. J., & Li, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.020 · Cited by 164
Říhová, B. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00404-8 · Cited by 162
Production of protein nanoparticles by electrospray drying
Gomez, A., Bingham, D., Juan, L. D., & Tang, K. (1998) · Journal of Aerosol Science · doi:10.1016/s0021-8502(97)10031-3 · Cited by 161
Strategies to prolong the plasma residence time of peptidedrugs
Pollaro, L., & Heinis, C. (2010) · MedChemComm · doi:10.1039/c0md00111b · Cited by 161
Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
Bressler, N. M., & Bressler, S. B. (2000) · PubMed · Cited by 160
Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection
Dass, C. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0558-8 · Cited by 159
Electrospray Encapsulation of Hydrophilic and Hydrophobic Drugs in Poly(L‐lactic acid) Nanoparticles
Valo, H., Peltonen, L., Vehviläinen, S., Karjalainen, M., Kostiainen, R., Laaksonen, T., & Hirvonen, J. (2009) · Small · doi:10.1002/smll.200801907 · Cited by 158
Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Fu, Q., Sun, J., Zhang, W., et al. (2009) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489209789206869 · Cited by 157
Buse, J. D., & El‐Aneed, A. (2010) · Nanomedicine · doi:10.2217/nnm.10.107 · Cited by 155
Polymer–drug conjugates as nano-sized medicines
Canal, F., Sanchis, J., & Vicent, M. J. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.003 · Cited by 153
Release from polymeric prodrugs: Linkages and their degradation
D'Souza, A. J. M., & Topp, E. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20096 · Cited by 150
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting
Morille, M., Montier, T., Legras, P., Carmoy, N., Brodin, P. M., Pitard, B., Benoît, J., & Passirani, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.044 · Cited by 144
Xin, H., Chen, L., Gu, J., Ren, X., wei, Z., Luo, J., Chen, Y., Jiang, X., Sha, X., & Fang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.005 · Cited by 140
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
Swenson, C. E., Perkins, W. R., Roberts, P., & Janoff, A. S. (2001) · The Breast · doi:10.1016/s0960-9776(01)80001-1 · Cited by 136
Kiss, É., Bertóti, I., & Vargha-Butler, E. I. (2002) · Journal of Colloid and Interface Science · doi:10.1006/jcis.2001.7954 · Cited by 135
In vitro study of GDNF release from biodegradable PLGA microspheres
Aubert‐Pouëssel, A., Venier‐Julienne, M., Clavreul, A., Sergent, M., Jollivet, C., Montero‐Menei, C. N., Garcion, E., Bibby, D. C., Meneï, P., & Benoît, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.012 · Cited by 129
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers
Grabnar, P. A., & Kristl, J. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.569763 · Cited by 127
Long-Acting Risperidone: A Review of Its Use in Schizophrenia
Harrison, T. S., & Goa, K. L. (2004) · CNS Drugs · doi:10.2165/00023210-200418020-00005 · Cited by 125
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles
Wartlick, H., Spänkuch-Schmitt, B., Strebhardt, K., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.029 · Cited by 123
Müller, H., Löning, L., Horn, A., Schwabe, D., Gunkel, M., Schrappe, M., von Schütz, V., Henze, G., da Palma, J. C., Ritter, J., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02187.x · Cited by 120
Role of oxygen in biodegradation of poly(etherurethane urea) elastomers
Schubert, M. A., Wiggins, M. J., Anderson, J. M., & Hiltner, A. (1997) · Journal of Biomedical Materials Research · Cited by 119
Pharmacokinetics of Once-a-Month Injectable Microspheres of Leuprolide Acetate
Okada, H., Inoue, Y., Heya, T., Ueno, H., Ogawa, Y., & Toguchi, H. (1991) · Pharmaceutical Research · doi:10.1023/a:1015818504906 · Cited by 116
Cirstoiu-Hapca, A., Bossy-Nobs, L., Buchegger, F., Gurny, R., & Delié, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.002 · Cited by 116
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Madani, S. Y., Naderi, N., (17249869), O. D., Tan, A., & Seifalian, A. M. (2024) · Figshare · Cited by 116
Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles
Lu, Y., Huang, J.-Y., Wang, H., Lou, X.-F., Liao, M.-H., Hong, L.-J., Tao, R., Ahmed, M. M., Shan, C.-L., Wang, X.-L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.093 · Cited by 113
Gabizón, A., Goren, D., FUKS, Z. Y., Barenholz, Y., Dagan, A., & Meshorer, A. (1983) · PubMed · Cited by 111
Stopeck, A., Jones, A., Hersh, E. M., Thompson, J. A., Finucane, D., Gutheil, J. C., & Gonzalez, R. C. (2001) · PubMed · Cited by 111
Phase I Study of Liposomal Vincristine
Gelmon, K. A., Tolcher, A., Diab, A. R., Bally, M. B., Embree, L., Hudon, N. J., Dedhar, C., Ayers, D., Eisen, A. F., Melosky, B., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.697 · Cited by 108
Santos, N. D., Cox, K. A. K., McKenzie, C., van Baarda, F., Gallagher, R. C., Karlsson, G., Edwards, K., Mayer, L. D., Allen, C. J., & Bally, M. B. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.11.016 · Cited by 106
Polymeric nanoparticles as delivery system for influenza virus glycoproteins
Lemoine, D., & Véronique Préat, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00241-1 · Cited by 104
Nanotechnology for Nanomedicine and Delivery of Drugs
Venugopal, J. R., Prabhakaran, M. P., Low, S., Choon, A. T., Zhang, Y., Deepika, G., & Ramakrishna, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740180 · Cited by 103
Self-citationWang, Z., & Ho, P. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.075 · Cited by 102
Shen, Y., Zhan, Y., Tang, J., Xu, P., Johnson, P. A., Radosz, M., Kirk, E. A. V., & Murdoch, W. J. (2008) · AIChE Journal · doi:10.1002/aic.11600 · Cited by 102
Generating and loading of liposomal systems for drug-delivery applications
Cullis, P. R., Mayer, L. D., Bally, M. B., Madden, T. D., & Hope, M. J. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90024-0 · Cited by 98
Mylonakis, N., Athanasiou, A. E., Ziras, N., Angel, J., Rapti, A., Lampaki, S., Politis, N., Karanikas, C. A., & Kosmas, C. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.06.017 · Cited by 98
Andreas, K., Zehbe, R., Kazubek, M., Grzeschik, K., Sternberg, N., Bäumler, H., Schubert, H., Sittinger, M., & Ringe, J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.12.014 · Cited by 96
Deckert, J., Park, P. U., Chicklas, S., Yi, Y., Li, M., Lai, K. C., Mayo, M., Carrigan, C. N., Erickson, H. K., Pinkas, J., et al. (2013) · Blood · doi:10.1182/blood-2013-05-505685 · Cited by 94
Principal references used in Chemical Society Publications as from January, 1960
(1959) · Annual Reports on the Progress of Chemistry · doi:10.1039/ar9595600461 · Cited by 94
Fu, C. H., & Sakamoto, K. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1977 · Cited by 94
Kan, P., Tsao, C.-W., Wang, A.-J., Su, W.-C., & Liang, H.-F. (2010) · Journal of Drug Delivery · doi:10.1155/2011/629234 · Cited by 90
Factors affecting toxicity and efficacy of polymeric nanomedicines
Igarashi, E. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.007 · Cited by 90
A novel method for the preparation of biodegradable microspheres for protein drug delivery
Pareta, R. A., & Edirisinghe, M. J. (2006) · Journal of The Royal Society Interface · doi:10.1098/rsif.2006.0120 · Cited by 89
Heukers, R., Altıntaş, I., Raghoenath, S., Zan, E. D., Pepermans, R. A., Roovers, R. C., Haselberg, R., Hennink, W. E., Schiffelers, R. M., Kok, R. J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.001 · Cited by 83
Huang, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00060-5 · Cited by 79
Wen, H., Guo, J., Chang, B., & Yang, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.019 · Cited by 77
Vose, J. M. (2004) · The Oncologist · doi:10.1634/theoncologist.9-2-160 · Cited by 76
Bax, B. E., Bain, M. D., Fairbanks, L. D., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02059.x · Cited by 74
Kouchakzadeh, H., Shojaosadati, S. A., Tahmasebi, F., & Shokri, F. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.043 · Cited by 71
Alhareth, K., Vauthier, C., Gueutin, C., et al. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.01.025 · Cited by 71
Lee, H., Hu, M., Reilly, R. M., & Allen, C. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700559 · Cited by 65
Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer
Ninomiya, K., Kawabata, S., Tashita, H., & Shimizu, N. (2013) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.07.014 · Cited by 64
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments
Benesch, M., & Urban, C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.301 · Cited by 64
Size Dependent Liposome Degradation in Blood:In vivo/In vitroCorrelation by Kinetic Modeling
Harashima, H., Hiraiwa, T., Ochi, Y., & Kiwada, H. (1995) · Journal of drug targeting · doi:10.3109/10611869509015954 · Cited by 60
Liposomes in drug delivery: a patent review (2007 – present)
Arias, J. L. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.828035 · Cited by 51
Extended‐Release Epidural Morphine (DepoDur™): An Old Drug with a New Profile
Alam, M., & Hartrick, C. T. (2005) · Pain Practice · doi:10.1111/j.1533-2500.2005.00048.x · Cited by 45
Cited by
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Antitumor Activities of Metal Oxide Nanoparticles
Vinardell, M., & Mitjans, M. (2015) · Nanomaterials · doi:10.3390/nano5021004 · Cited by 337
Nanoscale Self-Assembly for Therapeutic Delivery
Yadav, S., Sharma, A. K., & Kumar, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00127 · Cited by 324
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
Metadata
- Authors
- Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 41
- Pages
- 178-195
- ISSN
- 0928-4931 (ISSN-L)
- OpenAlex
- W2078446103
- Cited by
- 253
- References
- 218
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.